GI
BNTC icon

GAMMA Investing’s Benitec Biopharma BNTC Stock Holding History

GAMMA Investing’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$107K Buy
7,961
+1,256
+19% +$14.9K ﹤0.01% 1765
2026
Q1 		$71.4K Sell
6,705
-20
-0.3% -$232 ﹤0.01% 1913
2025
Q4 		$90.6K Sell
6,725
-1
-0% -$14 ﹤0.01% 1651
2025
Q3 		$94.4K Buy
6,726
+734
+12% +$9.37K 0.01% 1540
2025
Q2 		$70.1K Buy
5,992
+27
+0.5% +$378 ﹤0.01% 1687
2025
Q1 		$77.6K Sell
5,965
-479
-7% -$5.79K 0.01% 1462
2024
Q4 		$81.4K Sell
6,444
-96
-1% -$1.04K 0.01% 1268
2024
Q3 		$60.1K Buy
6,540
+1,102
+20% +$9.86K 0.01% 1359
2024
Q2 		$38K Buy
5,438
+1,884
+53% +$13.9K 0.01% 1387
2024
Q1 		$18.7K Buy
3,554
+3,217
+955% +$12.3K ﹤0.01% 1700
2023
Q4 		$947 Buy
+337
New +$1.13K ﹤0.01% 2804

Other funds holding BNTC

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

GAMMA Investing's BNTC Position: Q2 2026 in Review

GAMMA Investing increased its Benitec Biopharma (BNTC) stake by 19% in Q2 2026, buying an estimated $14.9K and bringing the position to 7,961 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #1765.

GAMMA Investing first reported a position in BNTC in Q4 2023 and has held it in 11 quarters since. 7 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

  • GAMMA Investing held 7,961 shares of Benitec Biopharma worth $107K as of Q2 2026.
  • GAMMA Investing bought 1,256 Benitec Biopharma shares in Q2 2026, an estimated $14.9K.
  • Benitec Biopharma made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #1765 holding.
  • GAMMA Investing first reported a position in Benitec Biopharma in Q4 2023 and has held it in 11 quarters since.
  • 7 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.